JOURNAL OF PRACTICAL HEPATOLOGY ›› 2019, Vol. 22 ›› Issue (4): 474-477.doi: 10.3969/j.issn.1672-5069.2019.04.006

• Contents • Previous Articles     Next Articles

Protective effect of bee venom hemolysin on rats with nonalcoholic fatty liver disease

Wang Yan, Su Feng, Li Yuanyuan, et al   

  1. Department of Gastroenterology,Huxi Hospital Affiliated to Jining Medical College,Shanxian 274300,Shandong Province,China
  • Received:2018-07-01 Online:2019-07-10 Published:2019-07-19

Abstract: Objective To explore the protective effect of bee venom hemolysin on rats with nonalcoholic fatty liver disease (NAFLD).Methods Forty male SD rats were randomly divided into control,model,low-dose and high dose of bee venom hemolysin-intervened groups. Rats were fed with high fat to establish the NAFLD models,and the bee venom hemolysin peptide at doses of 10 μg·kg-1 and 100 μg·kg-1 or saline were subcutaneously injected daily for 12 weeks. Hepatic expression of nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) and heme oxygenase-1(HO-1) were detected by Western bloting.Results The body weight and liver mass of rats in high dose of bee venom hemolysin-intervened group were(380.2±20.8) g and(10.4±1.3) g,significantly lower than(435.2±22.1) g and (14.3±1.4) g in the model (P<0.05),serum AST and ALT levels were (88.0±10.4) U/L and (49.3±6.2) U/L,much lower than (159.7±18.9) U/L and (77.7±6.8) U/L in the model (P<0.05),blood glucose,TC,TG,and LDL-C levels were(8.7±1.8) mmol/L,(1.6±0.2) mmol/L,(0.8±0.1) mmol/L and (0.3±0.1)mmol/L,significantly lower than (18.3±2.4) mmol/L,(2.8±0.3) mmol/L,(1.5±0.2) mmol/L and (0.5±0.1)mmol/L,respectively in the model (P<0.05),serum superoxide dismutase(SOD),malondialdehyde(MDA) and glutathione(GSH) levels were (82.1±6.6)U/L,(6.3±0.8)nmol/mL and (8.7±0.9) mmol/L,significantly different as compared to (30.4±5.3)U/L,(13.1±1.6)nmol/mL and(2.3±0.5)mmol/L in the model(P<0.05),hepatic expression of Nrf2 and HO-1 were (1.4±0.2) and (1.2±0.1),significantly intensified as compared to(0.3±0.1) and (0.3±0.1) in the model (P<0.05). Conclusion Bee venom hemolytic peptide might alleviate hepatic steatosis in rats with non-alcoholic fatty liver disease and improve liver function,and the mechanism might be related to the regulation of Nrf2 and HO-1 expression and relieve oxidative stress injury.

Key words: Liver steatosis, Bee venom hemolytic peptide, Nuclear factor-erythroid 2 p45-related factor 2, Heme oxygenase-1, Rats